GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) » Definitions » Cash Flow for Dividends

Shanghai Fosun Pharmaceutical (Group) Co (SHSE:600196) Cash Flow for Dividends : ¥-2,059 Mil (TTM As of Dec. 2024)


View and export this data going back to 1998. Start your Free Trial

What is Shanghai Fosun Pharmaceutical (Group) Co Cash Flow for Dividends?

Shanghai Fosun Pharmaceutical (Group) Co's cash flow for dividends for the three months ended in Dec. 2024 was ¥-360 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2024 was ¥-2,059 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Shanghai Fosun Pharmaceutical (Group) Co's quarterly payment of dividends increased from Jun. 2024 (¥-333 Mil) to Sep. 2024 (¥-1,035 Mil) but then declined from Sep. 2024 (¥-1,035 Mil) to Dec. 2024 (¥-360 Mil).

Shanghai Fosun Pharmaceutical (Group) Co's annual payment of dividends increased from Dec. 2022 (¥-2,374 Mil) to Dec. 2023 (¥-2,455 Mil) but then declined from Dec. 2023 (¥-2,455 Mil) to Dec. 2024 (¥-2,059 Mil).

Shanghai Fosun Pharmaceutical (Group) Co Cash Flow for Dividends Historical Data

The historical data trend for Shanghai Fosun Pharmaceutical (Group) Co's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Fosun Pharmaceutical (Group) Co Cash Flow for Dividends Chart

Shanghai Fosun Pharmaceutical (Group) Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,834.64 -1,913.96 -2,374.37 -2,455.17 -2,059.42

Shanghai Fosun Pharmaceutical (Group) Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -361.91 -331.38 -333.24 -1,034.87 -359.92

Shanghai Fosun Pharmaceutical (Group) Co Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-2,059 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Fosun Pharmaceutical (Group) Co Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of Shanghai Fosun Pharmaceutical (Group) Co's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Fosun Pharmaceutical (Group) Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) » Definitions » Cash Flow for Dividends
Comparable Companies
SZSE:000963 SZSE:000999 SZSE:002001 SHSE:600085 SZSE:000661 SZSE:000423 SHSE:600079 SZSE:000513 SHSE:600518 SHSE:688506 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 NSE:DIVISLAB XTAE:TEVA
Traded in Other Exchanges
SFOSF:USA 02196:Hong Kong 08HH:Germany
Address
No. 1289 Yishan Road, Building A, Fosun Technology Park, Shanghai, CHN, 200233
Website
https://www.fosunpharma.com
Shanghai Fosun Pharmaceutical (Group) Co Ltd is engaged in the development, manufacture, and sale of pharmaceutical products and medical equipment, the import and export of medical equipment, and the provision of related and other consulting services and investment management. Its business segments are Pharmaceutical manufacturing, Healthcare Services, Medical devices, and medical diagnosis. It generates the majority of its revenue from the Pharmaceutical manufacturing segment. The company considers merger and acquisition investment as a potential component of its operational growth for expanding its research, development, manufacturing, and marketing capabilities. Its geographic areas are the Chinese mainland, Regions outside the Chinese mainland, and other countries.
Executives
Yao Fang Director
Wu Yi Fang Director
Wen De Yong Directors, senior managers
Guan Xiao Hui Director
Wang Ke Xin Director
Bao Qin Gui senior management
Mei Jing Ping senior management
Li Sheng Li senior management
Feng Rong Li senior management
Wang Dong Hua senior management
Dong Xiao Xian senior management
Su Li senior management
Zhu Yue senior management
Chen Yu Qing senior management
Hu Hang senior management

Shanghai Fosun Pharmaceutical (Group) Co Headlines

No Headlines